Gi

Clinical Assessment Framework for Medication Administration
  • Pre-Administration Assessment ("What to Check Before")

    • Baseline Vital Signs: Measure blood pressure, heart rate, respiratory rate, temperature, and oxygen saturation before administering medications that alter hemodynamics or central nervous system function.

    • Laboratory Values: Review relevant lab parameters, including renal function (BUN\text{BUN}, serum creatinine), hepatic function (ALT\text{ALT}, AST\text{AST}), electrolytes (e.g., potassium prior to loop diuretics or digoxin), and therapeutic drug levels.

    • Allergy and Medical History: Confirm documented allergies, specific historical reactions, current home medications to screen for interactions, and underlying organ dysfunctions.

    • System-Specific Physical Exam: Perform targeted baseline assessments (e.g., auscultating lung sounds prior to bronchodilators, checking baseline neurological status prior to sedatives).

Patient Presentation ("What the Patient Looks Like")
  • Evaluating Therapeutic Response

    • Observe for expected pharmacological outcomes (e.g., reduction in pain scale ratings, lowered blood pressure readings, decreased body temperature, cleared breath sounds).

    • Verify normalization of objective clinical markers and patient-reported symptom relief.

  • Recognizing Adverse Effects and Toxicity

    • Hypersensitivity / Anaphylaxis: Monitor for rash, urticaria, angioedema, wheezing, dyspnea, and acute hypotension.

    • Cardiovascular Signs: Watch for unexpected tachycardia, bradycardia, dysrhythmias, or extreme blood pressure fluctuations.

    • Neurological Signs: Assess for altered mental status, somnolence, agitation, confusion, ataxia, or neuromuscular irritability.

    • Renal and Fluid Signs: Monitor for oliguria (urine output <30 mL/hr< 30\,\text{mL/hr}), peripheral edema, or unexplained weight gain.

Critical Nursing Questions ("Nursing Perspective")
  1. Safety and Appropriateness

    • What is the clinical indication for this medication in this specific patient?

    • Is the ordered dose, route, and frequency safe based on age, weight, and renal/hepatic clearance?

    • Are there absolute contraindications or high-risk drug-drug interactions?

  2. Monitoring Parameters and Hold Criteria

    • What are the drug's onset, peak, and duration of action?

    • Are baseline laboratory or vital sign thresholds met, or does the medication need to be held (e.g., hold antihypertensives if systolic blood pressure <90 mmHg< 90\,\text{mmHg})?

    • Are peak and trough monitoring required for safe therapeutic dosing?

  3. Emergency Preparedness and Patient Education

    • Is a specific antidote or reversal agent required to be available (e.g., naloxone, flumazenil, protamine sulfate)?

    • What critical signs or precautions must be emphasized during patient discharge teaching?